Literature DB >> 16507865

The natural history of chronic obstructive pulmonary disease.

D M Mannino1, G Watt, D Hole, C Gillis, C Hart, A McConnachie, G Davey Smith, M Upton, V Hawthorne, D D Sin, S F P Man, S Van Eeden, D W Mapel, J Vestbo.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality in the USA, and it remains one of the few diseases that continues to increase its numbers. The development and progression of COPD can vary dramatically between individuals. A low level of lung function remains the cornerstone of COPD diagnosis and is a key predictor of prognosis. Lung function, however, is not the only factor in determining morbidity and mortality related to COPD, with factors such as body mass index, exercise capability and comorbid disease being important predictors of poor outcomes. Exacerbations of COPD are additional important indicators of both quality of life and outcomes in COPD patients. Definitions of exacerbations can vary, ranging from an increase in symptoms to COPD-related hospitalisations and death. COPD exacerbations are more common in patients with lower levels of lung function and may lead to more rapid declines in lung function. Better understanding of the natural history of COPD may lead to better definitions of specific COPD phenotypes, better interventions and improved outcomes.

Entities:  

Mesh:

Year:  2006        PMID: 16507865     DOI: 10.1183/09031936.06.00024605

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  67 in total

1.  Chronic obstructive pulmonary disease: a view from the NHLBI.

Authors:  Antonello Punturieri; Thomas L Croxton; Gail G Weinmann; James P Kiley
Journal:  Am J Respir Crit Care Med       Date:  2008-09-01       Impact factor: 21.405

2.  Predicting 1-year mortality rate for patients admitted with an acute exacerbation of chronic obstructive pulmonary disease to an intensive care unit: an opportunity for palliative care.

Authors:  Cassandra M Batzlaff; Craig Karpman; Bekele Afessa; Roberto P Benzo
Journal:  Mayo Clin Proc       Date:  2014-03-19       Impact factor: 7.616

3.  Greater Odds for Angina in Uranium Miners Than Nonuranium Miners in New Mexico.

Authors:  Vanessa J M Al Rashida; Xin Wang; Orrin B Myers; Tawny W Boyce; Elizabeth Kocher; Megan Moreno; Roger Karr; Nour Ass'ad; Linda S Cook; Akshay Sood
Journal:  J Occup Environ Med       Date:  2019-01       Impact factor: 2.162

4.  Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study.

Authors:  Debra A Stern; Wayne J Morgan; Anne L Wright; Stefano Guerra; Fernando D Martinez
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

Review 5.  Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges.

Authors:  Vanessa M McDonald; Isabel Higgins; Peter G Gibson
Journal:  Drugs Aging       Date:  2013-01       Impact factor: 3.923

Review 6.  The pharmacological approach to the elderly COPD patient.

Authors:  Timothy E Albertson; Michael Schivo; Amir A Zeki; Samuel Louie; Mark E Sutter; Mark Avdalovic; Andrew L Chan
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923

Review 7.  Particulate matter air pollution and respiratory impact on humans and animals.

Authors:  Caterina Losacco; Antonella Perillo
Journal:  Environ Sci Pollut Res Int       Date:  2018-10-04       Impact factor: 4.223

8.  Assessing treatment effects of inhaled corticosteroids on medical expenses and exacerbations among COPD patients: longitudinal analysis of managed care claims.

Authors:  Manabu Akazawa; Sally C Stearns; Andrea K Biddle
Journal:  Health Serv Res       Date:  2008-07-29       Impact factor: 3.402

Review 9.  Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives.

Authors:  Ruzena Tkacova
Journal:  Mediators Inflamm       Date:  2010-04-20       Impact factor: 4.711

10.  Caveolin-1 Expression and Hemodynamics in COPD Patients.

Authors:  Lars C Huber; Alex Soltermann; Manuel Fischler; Steffen Gay; Walter Weder; Erich W Russi; Rudolf Speich; Silvia Ulrich
Journal:  Open Respir Med J       Date:  2009-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.